Utah Medical Products Price to Sales Ratio 2010-2024 | UTMD
Historical PS ratio values for Utah Medical Products (UTMD) over the last 10 years. The current P/S ratio for Utah Medical Products as of April 22, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Utah Medical Products P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-04-22 | 53.59 | 4.63 | |
| 2024-12-31 | 61.14 | $11.57 | 5.28 |
| 2024-09-30 | 66.23 | $12.35 | 5.36 |
| 2024-06-30 | 65.84 | $12.91 | 5.10 |
| 2024-03-31 | 69.76 | $13.50 | 5.17 |
| 2023-12-31 | 82.27 | $13.81 | 5.96 |
| 2023-09-30 | 83.72 | $14.14 | 5.92 |
| 2023-06-30 | 90.41 | $14.27 | 6.34 |
| 2023-03-31 | 91.65 | $14.41 | 6.36 |
| 2022-12-31 | 96.91 | $14.33 | 6.76 |
| 2022-09-30 | 81.98 | $14.13 | 5.80 |
| 2022-06-30 | 82.28 | $14.01 | 5.87 |
| 2022-03-31 | 85.77 | $13.78 | 6.23 |
| 2021-12-31 | 95.13 | $13.41 | 7.09 |
| 2021-09-30 | 86.73 | $13.16 | 6.59 |
| 2021-06-30 | 79.20 | $12.59 | 6.29 |
| 2021-03-31 | 80.37 | $11.54 | 6.96 |
| 2020-12-31 | 78.00 | $11.47 | 6.80 |
| 2020-09-30 | 73.67 | $11.36 | 6.48 |
| 2020-06-30 | 81.45 | $11.84 | 6.88 |
| 2020-03-31 | 86.19 | $12.61 | 6.84 |
| 2019-12-31 | 98.56 | $12.55 | 7.85 |
| 2019-09-30 | 87.31 | $11.99 | 7.28 |
| 2019-06-30 | 86.94 | $11.41 | 7.62 |
| 2019-03-31 | 79.90 | $11.16 | 7.16 |
| 2018-12-31 | 74.98 | $11.20 | 6.70 |
| 2018-09-30 | 84.75 | $11.32 | 7.48 |
| 2018-06-30 | 98.82 | $11.26 | 8.77 |
| 2018-03-31 | 88.45 | $11.24 | 7.87 |
| 2017-12-31 | 72.62 | $11.09 | 6.55 |
| 2017-09-30 | 65.40 | $10.71 | 6.10 |
| 2017-06-30 | 64.15 | $10.56 | 6.07 |
| 2017-03-31 | 54.99 | $10.44 | 5.27 |
| 2016-12-31 | 63.93 | $10.42 | 6.14 |
| 2016-09-30 | 52.35 | $10.61 | 4.94 |
| 2016-06-30 | 54.92 | $10.69 | 5.14 |
| 2016-03-31 | 54.30 | $10.67 | 5.09 |
| 2015-12-31 | 50.61 | $10.65 | 4.75 |
| 2015-09-30 | 46.36 | $10.82 | 4.28 |
| 2015-06-30 | 51.07 | $11.03 | 4.63 |
| 2015-03-31 | 51.03 | $11.05 | 4.62 |
| 2014-12-31 | 50.98 | $10.94 | 4.66 |
| 2014-09-30 | 41.21 | $10.89 | 3.78 |
| 2014-06-30 | 43.26 | $10.70 | 4.04 |
| 2014-03-31 | 48.40 | $10.57 | 4.58 |
| 2013-12-31 | 47.62 | $10.74 | 4.43 |
| 2013-09-30 | 49.27 | $10.72 | 4.60 |
| 2013-06-30 | 44.79 | $10.88 | 4.12 |
| 2013-03-31 | 40.02 | $10.93 | 3.66 |
| 2012-12-31 | 29.43 | $11.22 | 2.62 |
| 2012-09-30 | 27.56 | $11.28 | 2.44 |
| 2012-06-30 | 26.99 | $11.43 | 2.36 |
| 2012-03-31 | 24.86 | $11.57 | 2.15 |
| 2011-12-31 | 21.41 | $10.39 | 2.06 |
| 2011-09-30 | 20.82 | $9.38 | 2.22 |
| 2011-06-30 | 20.45 | $8.13 | 2.52 |
| 2011-03-31 | 22.31 | $7.00 | 3.19 |
| 2010-12-31 | 20.57 | $6.90 | 2.98 |
| 2010-09-30 | 21.64 | $6.98 | 3.10 |
| 2010-06-30 | 18.28 | $7.11 | 2.57 |
| 2010-03-31 | 20.45 | $7.13 | 2.87 |
| 2009-12-31 | 21.15 | $7.15 | 2.96 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.172B | $0.041B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.162B | 27.40 |
| Boston Scientific (BSX) | United States | $140.689B | 37.90 |
| Stryker (SYK) | United States | $132.255B | 28.42 |
| EssilorLuxottica (ESLOY) | France | $128.431B | 0.00 |
| Medtronic (MDT) | Ireland | $105.938B | 15.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.424B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.151B | 26.20 |
| ResMed (RMD) | United States | $31.269B | 24.08 |
| Agilent Technologies (A) | United States | $29.217B | 19.30 |
| GE HealthCare Technologies (GEHC) | United States | $28.556B | 13.89 |
| Terumo (TRUMY) | Japan | $28.160B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.192B | 15.85 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.373B | 12.24 |
| Insulet (PODD) | United States | $17.332B | 74.11 |
| Baxter (BAX) | United States | $14.818B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.356B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.938B | 17.06 |
| Bio-Rad Laboratories (BIO) | United States | $6.672B | 23.10 |
| Demant (WILYY) | Denmark | $6.644B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.977B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.455B | 9.89 |
| ICU Medical (ICUI) | United States | $3.400B | 29.07 |
| Haemonetics (HAE) | United States | $2.872B | 13.52 |
| Envista Holdings (NVST) | United States | $2.614B | 20.80 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 14.75 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 44.47 |
| QuidelOrtho (QDEL) | United States | $1.698B | 14.22 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.214B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.189B | 18.67 |
| AdaptHealth (AHCO) | United States | $1.051B | 10.12 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 8.67 |
| Neogen (NEOG) | United States | $0.953B | 12.19 |
| Phibro Animal Health (PAHC) | United States | $0.700B | 10.74 |
| Evolus (EOLS) | United States | $0.686B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.649B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Owens & Minor (OMI) | United States | $0.535B | 4.56 |
| CeriBell (CBLL) | United States | $0.532B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Omeros (OMER) | United States | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.368B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.302B | 13.07 |
| Viemed Healthcare (VMD) | United States | $0.262B | 23.68 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.65 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.251B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 44.40 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Biote (BTMD) | United States | $0.181B | 4.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.175B | 0.00 |
| Brainsway (BWAY) | Israel | $0.155B | 48.47 |
| Jin Medical (ZJYL) | China | $0.147B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.42 |
| Agape ATP (ATPC) | $0.094B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Veru (VERU) | United States | $0.078B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.65 |
| Zynex (ZYXI) | United States | $0.066B | 24.22 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 11.61 |
| Apyx Medical (APYX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 51.50 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |